MyDay® family

*WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing googles or sunglasses because they do not completely cover the eye surrounding area. Persons should continue to use their protective UV-absorbing eyewear as directed.

† Vs. ACUVUE® OASYS MAX 1-Day, PRECISION1®, INFUSE® One-Day (US)/ULTRA® One-Day (ex-US).

‡ Vs. DAILIES TOTAL1® Multifocal & ACUVUE® OASYS MAX 1-Day MULTIFOCAL.

§ Vs. ACUVUE® OASYS 1-Day for ASTIGMATISM, PRECISION1® for Astigmatism & DAILIES TOTAL1® for Astigmatism.

| MyDay daily disposable orders includes MyDay Energys, MyDay daily disposable, MyDay daily disposable toric and MyDay daily disposable multifocal product(s) sold and distributed by CooperVision in the US.

¶ Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in MyDay daily disposable orders in a specified time period. MyDay daily disposable plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).

** Vs. DAILIES TOTAL1®, PRECISION1®, ACUVUE® OASYS MAX 1-Day, INFUSE® One-Day (US)/ULTRA® One-Day (ex-US).

†† Vs. DAILIES TOTAL1® Multifocal & ACUVUE® OASYS MAX 1-Day MULTIFOCAL at 2 weeks.

1. CVI data on file 2021 & 2023. MyDay® compared to PRECISION1® n=35 (dispense 9.1 vs 9.4 p=0.13, day 5 8.2 vs 8.4 p=0.39), INFUSE® One-Day/ULTRA® One-Day n=64 (dispense 9.3 vs 9.1 p=0.33, day 5 8.3 vs 8.7 p=0.13), ACUVUE® OASYS MAX 1-Day n=68 (dispense 93 vs 95 p=0.18, day 6 88 vs 91 p=0.06).

2. CVI data on file 2021 & 2023. MyDay® multifocal compared to DAILIES TOTAL1® Multifocal n=59 & ACUVUE® OASYS MAX 1-Day MULTIFOCAL n=56; no statistically significant differences (p>0.05) on dispensing, days 6 and 13 on application and throughout the day on days 6 and 13.

3. CVI data 2017, 2021 & 2023. MyDay® toric compared to ACUVUE® OASYS 1-Day for ASTIGMATISM n=20, PRECISION1® for Astigmatism n=47, DAILIES TOTAL1® for Astigmatism n=54; no statistically significant differences (p>0.05) at dispense & after 1 week daily wear on application and removal.

4. CVI data on file, 2024.

5. CVI data on file 2023. Based on prescription option combinations from available published sources (sph, cyl, axis, ADD) available across all SiHy daily disposable soft lenses in sph, toric and MF from CVI, JJV, B+L and Alcon in U.S. July 2023. Cosmetic CLs not included. Multiple base curve variants not included.

6. CVI Data on file, 2022.

7. CVI data on file 2015, 2021, 2023, and 2023. MyDay® clinical studies compared to DAILIES TOTAL1® n=22 (dispense -0.09 vs -0.10 p=0.624), PRECISION1® n=35 (dispense -0.14 vs -0.14 p=0.90, 1 week -0.14 vs -0.15 p=0.14), ACUVUE® OASYS MAX 1-Day n=68 (dispense -0.10 vs -0.11 p=0.22, 1 week -0.10 vs -0.10 p=0.25), and INFUSE n=64 (dispense -0.04 vs -0.04 p=0.79, 1 week -0.04 vs -0.04 p=0.54).

8. CVI data on file 2021 & 2023. MyDay® compared to DAILIES TOTAL1® Multifocal n=59 (day 13 far distance 2.10 vs 2.02 p=0.24, intermediate distance 2.03 vs 1.79 p=0.01, near distance 1.88 vs 1.54 p=0.001) & ACUVUE® OASYS MAX 1-Day MULTIFOCAL n=56 (insertion 91 vs 93 p=0.25, removal 86 vs 88 p=0.30).

9. CVI data on file 2017, 2021 & 2023. MyDay® toric compared to ACUVUE® OASYS 1-Day for ASTIGMATISM n=20, PRECISION1® for Astigmatism n=47, DAILIES TOTAL1® for Astigmatism n=54; no statistically significant differences in distance visual acuity (p>0.05) at dispense & after 1 week daily wear.

10. CVI data on file, 2023. US industry reports and internal estimates.

11. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers.

12. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® multifocal; n=104 habitual multifocal contact lens wearers.

13. CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® multifocal; n=58 habitual multifocal contact lens wearers.